文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

基于生物标志物的脓毒症分型算法的时间稳健性

Temporal robustness of biomarker-based classification algorithms for sepsis.
PubMed 文献 · Intensive Care Med · 2025-12-01
一句话结论脓毒症免疫分型在入住ICU后短时间内频繁变化,约三分之一亚组同伴在每个时间点发生改变,提示单时间点生物标志物分型的临床实用性受限。

该研究分析两个ICU队列共345例脓毒症患者,每8小时测量30种免疫生物标志物,持续至7天,用潜在剖面分析在入ICU时识别免疫分型并在后续时间点重新分类。入ICU时识别出三种免疫分型:A型(149例,43%)为适应性免疫激活,B型(60例,17%)为高炎症状态,C型(136例,39%)为广泛炎症抑制。48小时后A型和B型占比分别降至31%和13%,C型升至56%。跨类转换在A型患者中最常见(占所有8小时间隔转换的41%),类内凝聚性差(中位Rand指数65%,IQR 62-64%),表明入ICU时归为同类的患者并未持续保持在一起。结论认为分型不稳定挑战了生物标志物衍生内型的临床实用性。

要点

  • 入ICU时三种免疫分型占比:A型149例(43%)、B型60例(17%)、C型136例(39%)。
  • 48小时后A型和B型占比分别降至31%和13%,C型升至56%。
  • 跨类转换在A型患者中最常见,占所有8小时间隔转换的41%,B型和C型分别为39%和22%。
  • 类内凝聚性差,中位Rand指数65%(IQR 62-64%),入ICU时同类患者后续未持续保持在一起。
  • 约三分之一亚组同伴在每个时间点发生改变,分型不稳定挑战生物标志物衍生内型的临床实用性。

适用人群与场景

  • 两个ICU队列共345例脓毒症患者。

研究设计与关键结果

  • 研究类型为对两个ICU队列345例脓毒症患者的分析,每8小时测量30种免疫生物标志物,持续至7天,用潜在剖面分析在入ICU时识别分型并在后续时间点重新分类。
  • 入ICU时识别三种免疫分型:A型149例(43%)反映适应性免疫激活(IL-4、IL-5、RANTES和GM-CSF升高);B型60例(17%)为高炎症状态(IL-6、IL-8、IL-1Ra高且蛋白C低);C型136例(39%)为广泛炎症抑制。
  • 48小时后A型和B型占比分别降至31%和13%,C型升至56%。
  • 跨类转换在A型患者中最常见(占所有8小时间隔转换的41%),B型和C型分别为39%和22%。
  • 类内凝聚性差,中位Rand指数65%(IQR 62-64%),表明入ICU时归为同类的患者并未持续保持在一起。

证据类型、等级与局限

  • 证据类型为对两个ICU队列数据的分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为分型不稳定挑战了生物标志物衍生内型的临床实用性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Heterogeneity of the host response in sepsis hampers development of effective treatments. Several immunobiologically distinct subphenotypes (or endotypes) have been identified using data-driven analyses of single-timepoint biomarker data, but their temporal stability remains uncertain due to dynamic biology and statistical limitations.

METHODS: We analyzed data from 345 sepsis patients across two ICU cohorts. 30 immune biomarkers were measured every 8 h for up to 7 days. Latent profile analysis was used to identify classes upon admission and re-classify patients at later timepoints. Temporal robustness was assessed by (1) inter-class transition rates, and (2) intra-class cohesion (regardless of label) using the Rand Index (RI).

RESULTS: At ICU admission, three immune profiles were identified: profile A (149 patients, 43%) reflected adaptive immune activation (elevated IL-4, IL-5, RANTES, and GM-CSF); profile B (60 patients, 17%) a hyperinflammatory state (high IL-6, IL-8, IL-1Ra, and low protein C); and profile C (136 patients, 39%) broadly attenuated inflammation. By 48 h, the prevalences of A and B declined to 31% and 13%, while C increased to 56%. Inter-class transitions occurred most in patients assigned to A (41% of all 8-hourly transitions), compared to 39% and 22% for B and C. Intra-class cohesion across intervals was poor (median RI 65%, IQR 62-64%), indicating that patients classified together at admission did not remain consistently together.

CONCLUSION: Sepsis patients were frequently reclassified across immune profiles over short intervals, with approximately one-third of subgroup peers changing at each timepoint. This instability challenges the clinical utility of biomarker-derived endotypes.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Rademaker E, van Amstel RBE, El Bouhaddani S, et al. Temporal robustness of biomarker-based classification algorithms for sepsis. Intensive Care Med. 2025. PMID: 41324692. doi:10.1007/s00134-025-08218-z

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。